Aenova set to allocate, OID kept at 99
The €297.5m of leveraged loans backing BC Partners’ buyout of German pharmaceutical company Aenova will be allocated to investors on Friday after the deal received a "solid" response from investors, according to a banker close to the deal.
"The loans were not wildly oversubscribed, and syndication went as expected, so we didnt consider a reverse flex," said the banker.
Aenovas term loan B was issued with an original issue discount of 99 as guided by the bookrunners when the deal was launched.
JP Morgan is bookrunner on
Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: firstname.lastname@example.org
To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: email@example.com or find out more online here.